Antimicrobial resistance causes over 700,000 deaths annually. One Health Day reminds us why innovations like EVOQ metamaterials are crucial.
One Health Day highlights the interconnected nature of human, animal, and environmental health. Observed on Nov. 3, this day encourages global collaboration to address shared challenges like antimicrobial resistance and pathogen spread. The EVOQ metamaterial platform is aiming to contribute to these efforts by providing stable, non-ionic solutions that reduce infection risks across sectors. These metamaterials, produced through a unique high-energy laser ablation process, offer uniform spheres that integrate into a variety of products. This approach supports One Health principles by tackling pathogens in healthcare, agriculture, and the environment without triggering resistance or cytotoxic effects. Third-party, in vitro testing has shown the incredible effectiveness of these metamaterials against bacteria such as E. coli and Pseudomonas aeruginosa . As industries adopt these technologies, they foster healthier ecosystems for all.
EVOQ metamaterial platform powers antimicrobial innovation
EVOQ metamaterial platform overcomes longstanding material science challenges to deliver consistent performance. The EVOQ platform technology eliminates the need for capping agents, ensuring stability without ion emission. The lack of an oxidative layer is what differentiates EVOQ metamaterial from others. These metallic allotropes can be created from any solid metal on the periodic table and synthesized into various materials. These features enable atomic-level interactions that enhance applications in diverse fields.
In healthcare, the platform addresses infection risks in medical devices. EVQ-218, a key product from this technology, is being tested on catheters, needle-free connectors, and other consumables. Dozens of in vitro testing has been done with breathtaking results. These tests have shown the uniform structure can reduce bacterial adhesion and biofilm, which helps lower the risk of device-related infections like catheter-associated urinary tract infections (CAUTIs). Testing shows effectiveness against pathogens including Staphylococcus aureus and Pseudomonas aeruginosa . Major medical device manufacturers and third-party labs have been able to validate these results, demonstrating its potential in real-world scenarios.
Beyond medical devices, the platform extends to textiles and surfaces through FUZE technology. FUZE F1 incorporates metamaterials into fabrics to repel bacteria and odors, maintaining freshness through hundreds of washes. This stability improves fabric integrity and reduces wear, making it suitable for sportswear, linens, and apparel. Surface treatments apply the same principles to hospitals, gyms, and public spaces, where they combat bacteria, fungi, and mold. These applications align with sustainability goals by minimizing chemical use and extending product life. FUZE already has three registrations with the EPA.
The scalability of the production process stands out, with costs orders of magnitude lower than conventional nanoscale synthesis methods. This efficiency makes advanced antimicrobial solutions more accessible, enabling wider adoption. Innovators across industries can leverage this platform to develop products that prioritize safety and performance. Ongoing research reveals new possibilities, from energy storage to environmental purification. In agriculture, metamaterials show promise in food packaging to reduce bacterial outbreaks and recalls, supporting food safety without harsh additives.
EVQ-218 transforms medical device performance
EVQ-218 exemplifies how the EVOQ metamaterial platform can advance healthcare applications. In laboratory and benchtop testing, EVQ-218 has shown strong preclinical results against antimicrobial resistance, including activity across all six ESKAPE pathogens with no detected resistance after serial passage (Sakawa Sharif et al., Antibiotics 2026). This metamaterial can be embedded directly into devices, bridging laboratory performance into device applications. EVQ-218 has also shown promise as an anti-encrustation agent in laboratory testing, with reduced encrustation observed under assay conditions. These results could support longer device service intervals in future applications.
Integration proves straightforward, adapting to existing manufacturing workflows. Simple synthesis or coating methods ensure compatibility with catheters, implants, and consumables. This ease reduces production complexity and costs, facilitating quick implementation. Third-party testing, including trials by contract manufacturing organizations, confirms the reliability of both synthesized and coated materials. Results indicate consistent antimicrobial activity without promoting resistance, a critical factor in combating superbugs.
Healthcare professionals can gain confidence from these pre-clinical outcomes. EVQ-218 outperforms traditional coatings by providing durable protection that withstands clinical demands. In settings prone to healthcare-associated infections (HAIs), this technology could help improve patient outcomes and operational efficiency.
Antimicrobial textiles promote everyday health
FUZE technology harnesses the EVOQ platform technology to create resilient textiles that resist microbial growth. Incorporated during manufacturing, these metamaterials deliver antibacterial properties that endure repeated use. Gym gear, apparel, and home goods stay fresher longer, reducing the need for frequent washing and conserving water and energy.
A notable partnership with Allied Down + Feather introduces ExpeDRY, a down insulation enhanced with gold metamaterials. This solution accelerates drying without chemicals, maintaining insulation integrity in wet conditions. Unlike conventional hydrophobic treatments that degrade over time, ExpeDRY operates at the molecular level for sustained performance. Outdoor enthusiasts and apparel brands appreciate this chemical-free approach, which preserves the lightweight, packable qualities of down.
Surface applications extend these benefits to high-traffic areas. Treatments on hospital linens, gym equipment, and public surfaces minimize pathogen hiding spots. By eliminating the reliance on harsh chemicals, these solutions support eco-friendly practices while enhancing hygiene. Brands adopting FUZE contribute to global sustainability efforts, meeting consumer demands for durable, responsible products.
Broader solutions impact environmental and agricultural health
EVOQ metamaterial platform reaches beyond healthcare and textiles into environmental and agricultural domains. In energy storage, it boosts battery efficiency and capacity, potentially up to 700%, promoting cleaner energy alternatives. Environmental purification applications remove pollutants from air and water, reducing harmful byproducts and supporting ecosystem health.
Agricultural innovations include metamaterial-enhanced food packaging with the potential to curb bacterial growth, help prevent outbreaks, and reduce recalls. These measures could protect food supply chains, aligning with One Health by safeguarding human and animal health through safer produce handling. The non-emissive, non-leaching nature of the metamaterials ensures no environmental contamination, fostering sustainable practices.
Ongoing trials with industry leaders are uncovering additional uses for this technology. From consumer goods to advanced sectors, EVOQ platform technology is making an impact. Innovators are encouraged to submit inquiries to explore collaborations, accelerating the development of solutions that address interconnected health challenges.